Stig Atvall, författare på Dagensdiabetes - Sida 105 av 484

Författare: Stig Atvall

Arkiv alla nyheter

EASD. Tirzepatide and semaglutide GLP-1, SGLT2-i, Kerendia in T2DM. New datai

september 24, 2022 11:21 f m

EASD. Need of more recycling in diabetes technology

september 24, 2022 7:49 f m

EASD. Sex difference in care and outcome in young T1DM

september 24, 2022 7:44 f m

EASD. T2DM and life expectancy in UK

september 24, 2022 7:41 f m

Samband diabetes och UVI. Karolinska studie. Nature Comm

september 24, 2022 7:34 f m

Vaccinera mot pneumokocker vid diabetes. Folklhälsomyndigheten

september 24, 2022 7:30 f m

EASD. Nerve damage in eyes begins long before T2DM

september 24, 2022 7:28 f m

EASD. Cold exposure combat T2DM

september 24, 2022 7:24 f m

EASD. 52% more risks for T2DM after hysterectomy

september 24, 2022 7:22 f m

EASD. UK trial. Remission from T2DM possible

september 24, 2022 7:15 f m

Please Enable JavaScript in your Browser to Visit this Site.

#mdp-ungrabber-js-disabled { position: fixed; top: 0; left: 0; height: 100%; width: 100%; z-index: 999999; text-align: center; background-color: #FFFFFF; color: #000000; font-size: 40px; display: flex; align-items: center; justify-content: center; }